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repressed and Notch3 is not a target of any Numb protein. The
ability of Numb isoforms to relieve Notch mediated repression
of MyoD-induced myogenic conversion of C3H10T1/2 cells
recapitulated the data from the transcription assays. The ability
of Numb proteins to induce ubiquitination of the Notch
receptors was examined. These data indicate a varying ability
of Numb isoforms to effectively modulate the function of
specific Notch receptors and their downstream signaling.
doi:10.1016/j.ydbio.2007.03.193
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Sorcin is a 21.6-kDa Ca2+ binding protein with 5 EF hands
motifs. It has been implicated in the regulation of intracellular
Ca2+ cycling and in cardiac excitation–contraction coupling
known as the Ca2+ induce Ca2+-release (CICR) by the
inhibition of the type 2 Ryanodine receptor (RyR2) activity.
We have demonstrated that Sorcin inhibits the activity of the
type 2 Ryanodine receptor both in mouse cardiomyocytes in
vitro and in lipid bilayer assays. Three types Ryanodine recep-
tors exist, type 1 is expressed in the skeletal muscle, type 2 is
expressed in cardiac muscle, whereas the type 3 is expressed in
brain tissue. Since Sorcin seems to have and important role in
calcium homeostasis and it could be a calcium buffer in the
heart and other developing organs, we analyzed its expression
during embryonic development in mouse embryos. Using
fluorescent inmunostaining, we studied the expression of Sorcin
in mouse embryos from 9 to 12 days of gestational age (E9 to
E112). In addition to the expected expression in the heart, in E9
to E11 embryos we observed prominent expression in neuronal
groups of the central and peripheral nervous system. Our results
suggest two possibilities. First, since the cardiovascular system
is one of earliest to develop and the heartbeat begins at E8, we
think it is likely that Sorcin regulates the activity of the cardiac
type Ryanodine receptor (RyR2) during early development.
Second, our results also suggest that Sorcin is involved in the
development of specific structures of the central and peripheral
nervous systems. We are grateful for the technical assistance of
Martín García Servín.
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Natriuretic peptides, beside their endocrine actions, have
paracrine functions including glucose uptake and metabolism.
Atrial natriuretic peptide (ANP) actions are mediated by cGMP
implicated in the metabolic adaptation of glucose metabolism to
oxygen deprivation in the heart. Although it has been reported
that ANP increases glucose uptake, cGMP decreases it. In this
paper we evaluate the role of the glucose transporters 1 and 4
(GLUTS), in glucose uptake produced by ANP in adult and
neonatal cardiomyocytes under oxygenation and hypoxia. We
also explored if the calcium–calmodulin complex participates
in ANP-induced increase in glucose uptake. Neonatal cells had
a higher glucose uptake than adult cells and GLUT 1 parti-
cipated in basal uptake in both cell types. Hypoxia increased
glucose uptake in adult cardiomyocytes but not in neonatal cells
and this increase in glucose uptake was mediated by GLUT4.
ANP increased glucose uptake in both adult and neonatal
myocytes, under oxygenation and hypoxia, and GLUT4 favored
this increase. Neonatal cells were less sensitive to ANP.
Trifluoperazine, a calcium–calmodulin blocker, inhibited the
ANP-induced increase in glucose uptake. This suggests that
ANP promotes GLUT 4 calcium-mediated recruitment to the
cell membrane. In conclusion, glucose uptake regulation is one
of the paracrine metabolic effects of ANP in adult and neonatal
cardiomyocytes under oxygenation and hypoxia. This effect of
this peptide could explain the beneficial effects found in the
internal medicine and surgical fields.
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Platelet derived growth factor receptors (PDGFR)α and β
are receptor tyrosine kinases involved in diverse cellular func-
tions essential for embryonic development. While analysis of
the null alleles has demonstrated independent roles for PDG-
FRα and PDGFRβ, the cooperative roles for the receptors
have yet to be determined. We found embryos lacking both
PDGFR resulted in embryonic lethality at E9.5 with disrupted
yolk sac vascular development. To investigate which cell
population was responsible for the aberrant vasculature, we
deleted the receptors in either the mesothelium or the vascular
smooth muscle cells (VSMC). We found that only deletion of
the receptors in the mesothelium lead to embryonic lethality at
E10.5 while loss of the receptors in VSMC resulted in normal
vasculature. The mutant yolk sacs formed a vascular plexus
similar to wild type; however, vascular remodeling failed to
occur. Proliferation and cell survival were normal in the
mutant yolk sac. Using markers for specific cell populations of
the yolk sac we determined there was a decrease in the VSMC
populations suggesting a role for the PDGFR in mesothelium
differentiation. Further analysis of mouse mutants deficient in
downstream signaling pathways of the receptors demonstrated
that PI3 kinase signaling was not essential for vascular
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